Cargando…

EE527 Cost-Effectiveness and Budget Impact Analysis of Remdesivir for the Treatment of COVID-19 in Greece

Detalles Bibliográficos
Autores principales:	Athanasakis, K, Nomikos, N, Tsoulas, C, Zisis, K
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Published by Elsevier Inc. 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9747494/ http://dx.doi.org/10.1016/j.jval.2022.09.768

Ejemplares similares

A Cost-Effectiveness and Budget Impact Analysis of AbobotulinumtoxinA in Greece
por: Nomikos, Nikolaos, et al.
Publicado: (2023)

Antibacterial Treatment of Meticillin-Resistant Staphylococcus Aureus Complicated Skin and Soft Tissue Infections: a Cost and Budget Impact Analysis in Greek Hospitals
por: Athanasakis, Kostas, et al.
Publicado: (2014)

527. Lower Risk of ICU Admission with Remdesivir in Patients Hospitalized with COVID-19 Pneumonia
por: Lim, Sarah, et al.
Publicado: (2021)

HPR118 An Updated Estimate of the Direct Cost of the COVID-19 Pandemic for the Greek Healthcare System
por: Athanasakis, K, et al.
Publicado: (2022)

Electrical Power Budget for FCC-ee
por: Aull, S., et al.
Publicado: (2016)

PNS21 From Disease Burden to Healthcare Cost: Highlighting the Health Economics Aspects of the COVID-19 Pandemic
por: Athanasakis, K., et al.
Publicado: (2020)

EE410 Cost-Effectiveness Analysis of Remdesivir for the Treatment of COVID-19 Hospitalized Adults in Three Countries of LATAM: Argentina, Chile, and Colombia
por: Montejano, R, et al.
Publicado: (2022)

Cost-effective osteoporosis treatment thresholds for people living with HIV infection in Greece
por: Makras, Polyzois, et al.
Publicado: (2017)

Cost–Benefit Analysis of Single versus Repeated Use of Single-Use Devices in Cataract Surgery
por: Naoum, Panagiota, et al.
Publicado: (2021)

Benefits of Minimizing the Vertex Detector Material Budget at the FCC-ee
por: Freitag, Leila
Publicado: (2023)

Don Giovanni KV 527
por: Mozart, Wolfgang Amadeus, 1756-1791
Publicado: (1992)

Cost-Sharing Rates Increase During Deep Recession: Preliminary Data From Greece
por: Gouvalas, Athanasios, et al.
Publicado: (2016)

Baricitinib + remdesivir cost saving vs remdesivir for hospitalised COVID-19 patients in the USA
Publicado: (2021)

Budget impact analysis of ustekinumab in the management of moderate to severe psoriasis in Greece
por: Avgerinou, Georgia, et al.
Publicado: (2012)

The Contribution of Greece to the Budget of CERN for 1979 and 1980
Publicado: (1978)

The Contribution of Greece to the Budget of CERN for 1979 and 1980
Publicado: (1978)

Cost-effectiveness of Remdesivir and Dexamethasone for COVID-19 Treatment in South Africa
por: Jo, Youngji, et al.
Publicado: (2021)

Cost-Effectiveness of Remdesivir for COVID-19 Treatment: What Are We Missing?
por: Chhatwal, Jagpreet, et al.
Publicado: (2022)

EE43 Budget Impact Analysis of Favipiravir (AVIGAN®) for the Treatment of Patients with Confirmed Infection with SARS-COV2 in Mexico
por: Paladio Hernández, JÁ, et al.
Publicado: (2022)

Remdesivir and COVID-19
por: Edwards, Jessie K, et al.
Publicado: (2020)

The Cost-Effectiveness of Remdesivir for Hospitalized Patients With COVID-19
por: Whittington, Melanie D., et al.
Publicado: (2022)

Remdesivir cost effective for severe COVID-19 in China
Publicado: (2021)

Amendment to the Contribution of Greece to the Budget of CERN for 1979 and 1980
Publicado: (1978)

Remdesivir and dexamethasone as tools to relieve hospital care systems stressed by COVID-19: A modelling study on bed resources and budget impact
por: Béraud, Guillaume, et al.
Publicado: (2022)

The place for remdesivir in COVID-19 treatment
por: Young, Barnaby, et al.
Publicado: (2021)

Costs and effects of paliperidone extended release compared with alternative oral antipsychotic agents in patients with schizophrenia in Greece: A cost effectiveness study
por: Geitona, Maria, et al.
Publicado: (2008)

Costs and effects of paliperidone extended release compared with alternative oral antipsychotic agents in patients with schizophrenia in Greece: a cost effectiveness study
por: Geitona, Maria, et al.
Publicado: (2009)

Cost-effectiveness of remdesivir for the treatment of hospitalized patients with COVID-19: a systematic review
por: Rezapour, Aziz, et al.
Publicado: (2023)

Closed Session The Contribution of Greece to the Budget of CERN for 1979 and 1980
Publicado: (1978)

Aiming towards hepatitis C virus elimination in Greece
por: Papatheodoridis, George V., et al.
Publicado: (2019)

Remdesivir for the Treatment of Covid-19 — Final Report
por: Beigel, John H., et al.
Publicado: (2020)

Sleep, Physical Activity, and Diet of Adults during the Second Lockdown of the COVID-19 Pandemic in Greece
por: Papazisis, Zisis, et al.
Publicado: (2021)

Costs associated with COVID-19 in healthcare personnel in Greece: a cost-of-illness analysis
por: Maltezou, H.C., et al.
Publicado: (2021)

Remdesivir and COVID-19
por: Ferrara, Francesco, et al.
Publicado: (2020)

Remdesivir for COVID-19
Publicado: (2020)

Remdesivir and COVID-19
por: Glaus, Matthew J, et al.
Publicado: (2020)

Remdesivir and COVID-19
por: Wang, Lei-Yun, et al.
Publicado: (2020)

Remdesivir and COVID-19
por: Dennis, Alicia
Publicado: (2020)

Impact of Remdesivir on the Treatment of COVID-19 During the First Wave in Spain
por: Soriano, Alejandro, et al.
Publicado: (2021)

Effects on LOS may not justify cost of remdesivir for severe COVID-19
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_peu1ed6imf3appgr8s8j0hudso